Learn More
SARS-CoV-2 Spike RBD LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | Spike RBD |
| Applications | Blocking Assay |
| Classification | Monoclonal |
| Clone | L009.1.32H |
| Conjugate | Unconjugated |
| Dilution | Blockade of Receptor-ligand Interaction 50 ug/mL |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. |
| Gene Accession No. | YP_009724390.1 |
| Host Species | Llama |
| Immunogen | Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.